- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stryker Corporation (SYK)
Stryker Corporation stock price live, this page displays NYSE SYK stock exchange data. View the SYK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Stryker Corporation real time stock price chart below.
What Is the Stryker Corporation Stock Price Today?
The Stryker Corporation stock price today is 369.53.
What Is the Stock Symbol for Stryker Corporation?
The stock symbol for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYK quote. (ISIN: US8636671013)
What Is the Stryker Corporation Stock Price Today?
The Stryker Corporation stock price today is 369.53.
What Is the Stock Symbol for Stryker Corporation?
The stock symbol for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYK quote. (ISIN: US8636671013)
369.53
+5.87(+1.61%)
Closed
After Hours
371.75+2.22(+0.60%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.61
371.76
52 wk Range
314.93
406.19
SYK Scorecard
Full Analysis
Has raised its dividend for 15 consecutive years
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.61371.76
52 wk Range
314.93406.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
424.43
Upside
+14.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Piper Sandler maintains $420 target on Stryker stock
- Investing.com
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Stryker Company Profile
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stryker Corporation SWOT Analysis
Financial Prowess | Stryker's robust Q4 2024 results showcase its financial strength, with 10.2% organic sales growth and impressive margins in key divisions like Hips and Knees |
Strategic Acquisitions | Explore Stryker's portfolio expansion through the Inari Medical and Vertos Medical acquisitions, positioning the company for growth in high-potential markets |
Innovation Leade | Delve into Stryker's dominance in medical robotics and its impact on market share, driving record adoption rates and fueling future growth prospects |
Analyst Optimism | Discover why analysts maintain a bullish outlook, with price targets ranging from $360 to $445, reflecting confidence in Stryker's long-term growth strategy |
Stryker Corporation Earnings Call Summary for Q3/2024
- Stryker reports 11.5% organic sales growth in Q3, with adjusted EPS of $2.87, up 16.7% year-over-year
- Full-year 2024 guidance narrowed to 9.5%-10% organic sales growth and adjusted EPS of $12-$12.10
- Strategic acquisitions completed, including Care.ai and NICO Corporation, to enhance healthcare IT and surgical offerings
- Record Mako installations achieved; orthopedic business shows above-market growth despite flat revenue from rental agreements
- Company aims for 200 basis point margin expansion by 2025, driven by innovation and strong procedural volumes
Last Updated: 31-10-2024, 01:46 am
Read Full TranscriptCompare SYK to Peers and Sector
Metrics to compare | SYK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 47.1x | −13.0x | −0.5x | |
PEG Ratio | −7.81 | 0.05 | 0.00 | |
Price/Book | 6.8x | 2.9x | 2.6x | |
Price / LTM Sales | 6.2x | 3.4x | 3.0x | |
Upside (Analyst Target) | 19.6% | 28.7% | 56.3% | |
Fair Value Upside | Unlock | −4.5% | 10.0% | Unlock |
Analyst Ratings
22 Buy
9 Hold
1 Sell
Ratings:
32 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 424.43
(+14.86% Upside)
Earnings
Latest Release
Jan 28, 2025
EPS / Forecast
4.01 / 3.87
Revenue / Forecast
6.40B / 6.36B
FAQ
What Is the Stryker (SYK) Stock Price Today?
The Stryker stock price today is 369.53.
What Stock Exchange Does Stryker Trade On?
Stryker is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Stryker?
The stock symbol for Stryker is "SYK."
Does Stryker Pay Dividends? What’s The Current Dividend Yield?
The Stryker dividend yield is 0.91%.
What Is the Stryker Market Cap?
As of today, Stryker market cap is 141.00B.
What is Stryker Earnings Per Share?
The Stryker EPS is 7.86.
What Is the Next Stryker Earnings Date?
Stryker will release its next earnings report on 29 Apr 2025.
From a Technical Analysis Perspective, Is SYK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.